These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7569795)

  • 21. [The urodynamic examination in prostatism].
    Svihra J; Poulsen AL; Schou J
    Rozhl Chir; 1993 Oct; 72(7):307-10. PubMed ID: 7508146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of silodosin for relieving benign prostatic obstruction: prospective pressure flow study.
    Matsukawa Y; Gotoh M; Komatsu T; Funahashi Y; Sassa N; Hattori R
    J Urol; 2009 Dec; 182(6):2831-5. PubMed ID: 19837428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is it possible to predict post-residual voided urine by bladder scan before uroflowmetry--a useful and timesaving test to reduce the number of non--evaluable uroflow measurements?
    Dicuio M; Vesely S; Knutson T; Damber JE; Cuzzocrea DE; Dahlstrand C
    Arch Ital Urol Androl; 2010 Jun; 82(2):100-4. PubMed ID: 20812533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diagnostic and differential diagnosis of benign prostate syndrome (BPS): guidelines of the German Urologists].
    Berges R; Dreikorn K; Höfner K; Madersbacher S; Michel MC; Muschter R; Oelke M; Reich O; Rulf W; Tschuschke C; Tunn U
    Urologe A; 2009 Nov; 48(11):1356-60, 1362-4. PubMed ID: 19756468
    [No Abstract]   [Full Text] [Related]  

  • 25. Why pressure-flow studies should be optional and not mandatory studies for evaluating men with benign prostatic hyperplasia.
    McConnell JD
    Urology; 1994 Aug; 44(2):156-8. PubMed ID: 7519379
    [No Abstract]   [Full Text] [Related]  

  • 26. Differential diagnosis of prostatism: A 12-year retrospective analysis of symptoms, urodynamics and satisfaction with therapy.
    Kaplan SA; Bowers DL; Te AE; Olsson CA
    J Urol; 1996 Apr; 155(4):1305-8. PubMed ID: 8632561
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Objective and subjective response criteria to diagnose benign prostatic hyperplasia.
    Roehrborn CG
    Eur Urol; 1993; 24 Suppl 1():2-11. PubMed ID: 7687554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differentiation between neurogenic and prostatic obstruction using the intraprostatic spiral. A case report.
    Ovesen H; Poulsen AL; Nordling J
    Scand J Urol Nephrol; 1990; 24(3):179-80. PubMed ID: 1700470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Responders and non-responders to treatment of benign prostatic hyperplasia with transurethral microwave thermotherapy.
    Eliasson TU; Abramsson LB; Pettersson GT; Damber JE
    Scand J Urol Nephrol; 1995 Jun; 29(2):183-91. PubMed ID: 7569796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variability of pressure-flow analysis parameters in repeated cystometry in patients with benign prostatic hyperplasia.
    Rosier PF; de la Rosette JJ; Koldewijn EL; Debruyne FM; Wijkstra H
    J Urol; 1995 May; 153(5):1520-5. PubMed ID: 7536260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Contribution of pressure-flow relationship studies in the evaluation of benign hypertrophy of the prostate].
    Haab F
    Prog Urol; 1999 Feb; 9(1):151-5. PubMed ID: 10212970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urodynamics in prostatism. I. Prognostic value of uroflowmetry.
    Jensen KM; Jørgensen JB; Mogensen P
    Scand J Urol Nephrol; 1988; 22(2):109-17. PubMed ID: 2462745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [S2e guideline of the German urologists: Conservative and pharmacologic treatment of benign prostatic hyperplasia].
    Höfner K; Bach T; Berges R; Dreikorn K; Gratzke C; Madersbacher S; Michel MS; Muschter R; Oelke M; Reich O; Tschuschke C; Bschleipfer T
    Urologe A; 2016 Feb; 55(2):184-94. PubMed ID: 26518303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of transurethral catheterization on uroflow rate in the pressure-flow study of patients with benign prostatic hyperplasia].
    Zhao SC; Zheng SB; Tan WL; Mao XM; Zhang P; Huang ZM; Zhang HJ; Zuo Y
    Zhonghua Nan Ke Xue; 2007 Aug; 13(8):710-2. PubMed ID: 17918710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Local hyperthermia in benign prostatic hyperplasia].
    Bichler KH; Strohmaier WL; Flüchter SH
    Urologe A; 1991 Mar; 30(2):122-6. PubMed ID: 1711728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prediction of clinical outcome from transurethral microwave thermotherapy by pressure-flow analysis: a European multicenter study.
    Tubaro A; Carter SS; de la Rosette J; Höfner K; Trucchi A; Ogden C; Miano L; Valenti M; Jonas U; Debruyne F
    J Urol; 1995 May; 153(5):1526-30. PubMed ID: 7536261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-energy transurethral microwave thermotherapy: a thermoablative treatment for benign prostatic obstruction.
    de Wildt MJ; Debruyne FM; de la Rosette JJ
    Urology; 1996 Sep; 48(3):416-23. PubMed ID: 8804495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endoscopic balloon dilation of the prostate: early experience.
    Goldenberg SL; Perez-Marrero RA; Lee LM; Emerson L
    J Urol; 1990 Jul; 144(1):83-7; discussion 87-8. PubMed ID: 1694251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transurethral thermotherapy for benign prostatic hyperplasia significantly decreases infravesical obstruction: results in 134 patients after 1 year.
    Thalmann GN; Graber SF; Bitton A; Burkhard FC; Gruenig O; Studer UE
    J Urol; 1999 Aug; 162(2):387-93. PubMed ID: 10411044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Noninvasive assessment of prostatic obstruction in elderly men with lower urinary tract symptoms associated with benign prostatic hyperplasia.
    van Venrooij GE; Eckhardt MD; Boon TA
    Urology; 2004 Mar; 63(3):476-80. PubMed ID: 15028441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.